1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Healthcare Plans
CVS Health Corporation

CVS Health Corporation

CVS.DE
CVS Health CorporationDE flagDeutsche Börse
91.26
EUR
+1.24
- -
116.44BMarket Cap
CVS Health Corporation
CVS.DE
(Deutsche Börse)

Recent

price

91.26

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
70.06
80.03
96.87
104.16
120.04
137.11
165.47
181.16
186.38
197.37
205.28
221.46
245.78
278.42
296.12
317.34
321.27
Revenue per Share
2.51
2.59
3.04
3.77
4
4.68
4.96
6.49
-0.57
5.1
5.48
6.07
3.29
6.49
3.66
1.4
2.31
Basic EPS, GAAP
2.03
2.98
3.65
3.12
5.17
5.52
7.38
5.97
6.54
7.99
10.26
11.94
10.25
8.09
5.02
6.16
5.82
Free Cash Flow per Basic Share
0.35
0.5
0.65
0.9
1.11
1.41
1.71
2.01
1.95
2
2
1.99
2.22
2.44
2.68
2.68
2.68
Dividend per Share
14.13
16.52
19.68
23.43
27.45
31.77
36.35
74.17
82.71
70.01
73.46
77.55
79.72
86.07
89.36
88.08
89.76
Book Value per Share
1.67
1.29
1.18
1.53
0.04
-13.22
-13.91
-14.1
-54.27
-37.43
-31.32
-24.84
-23.77
-34.14
-34.05
-28.1
-25.92
Tangible Book Value per Share
1,367
1,338
1,271
1,217
1,161
1,118
1,073
1,020
1,044
1,301
1,309
1,319
1,312
1,285
1,259
1,267
1,270
Basic Weighted Avg Shares
95,778
107,080
123,120
126,761
139,367
153,290
177,546
184,786
194,579
256,776
268,706
292,111
322,467
357,776
372,809
402,067
407,905
Sales/Revenue/Turnover
6.41
5.91
5.86
6.34
6.31
6.18
5.85
5.26
5.23
4.76
5.18
5.17
5.05
4.08
2.6
2.58
2.87
Operating Margin (%)
1,469
1,568
1,753
1,870
1,931
2,092
2,475
2,479
2,718
4,371
4,441
4,486
4,224
4,366
4,597
4,606
4,567
Depreciation Expense
3,427
3,462
3,864
4,592
4,644
5,237
5,317
6,622
-594
6,634
7,179
8,001
4,311
8,344
4,614
1,768
2,932
Net Income, GAAP
38.9
39.29
38.64
38.89
39.5
39.3
38.4
19.8
142.39
26.3
26.29
24.18
25.86
25.11
25.41
19.1
16.03
Effective Tax Rate (%)
3.58
3.23
3.14
3.62
3.33
3.42
2.99
3.58
-0.31
2.58
2.67
2.74
1.34
2.33
1.24
0.44
0.72
Profit Margin (%)
6,636
6,638
6,011
9,900
6,956
5,989
4,792
581
1,234
-3,001
-5,648
-7,799
-3,788
-11,331
-15,964
-13,978
-11,589
Working Capital
8,652
9,208
9,133
12,841
11,630
26,267
25,615
22,181
71,444
83,625
77,964
70,148
67,276
74,672
75,426
74,145
73,861
LT Debt
37,734
38,051
37,653
37,938
37,963
37,203
36,834
37,695
58,543
64,170
69,701
75,381
71,769
76,636
75,730
75,382
77,637
Total Equity
7.92
8.02
9.26
9.94
10.42
9.96
9.92
12.08
-4.38
6.32
6.66
7.48
8.22
7.33
4.6
5.35
6.25
Return on Invested Capital (%)
13.2
12.42
12.57
12.79
11.57
10.68
9.23
8.83
-1.3
5.21
5.14
5.5
3.38
5.64
3.55
2.24
2.88
Return on Capital (%)
19.2
16.71
16.4
17.16
15.38
15.54
14.27
11.55
-0.73
7.48
7.67
8.06
4.17
7.76
4.14
1.58
2.58
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
7,237
5,805
4,484
LT Borrowings
60,508
60,502
60,531
LT Finance Leases
14,007
13,643
13,330
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
1,270
1,271
1,273
Market Capitalization
94,266
101,243
90,799

Working Capital

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
77,109
74,714
74,817
Cash, Cash Equivalents & STI
11,232
10,598
11,802
Accounts Receivable, Net
16,099
16,316
20,144
Inventories
18,962
19,246
17,770
Total Current Liabilities
92,695
88,692
86,406
Payables & Accruals
84,362
81,771
80,847
ST Debt
7,237
5,805
4,484
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
8.34%
1.7%
-0.46%
Free Cash Flow
6.3%
-7.15%
23.41%
Net Income, GAAP
-133.9%
-9.5%
-61.68%
Sales/Revenue/Turnover
10.39%
8.42%
7.85%
Total Cash Common Dividend
8.3%
5.38%
0.71%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
88,437
91,234
95,428
97,710
372,809
2025
94,588
98,915
102,871
105,693
402,067
2026
100,426
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.88
1.41
0.07
1.31
3.66
2025
1.41
0.81
- -
2.32
1.4
2026
2.31
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.67
0.68
0.66
0.67
2.68
2025
0.67
0.68
- -
0.67
2.68
2026
0.67
- -
- -
- -
- -
Similar Companies
Elevance Health Inc. (ANTM)
Bright Health Group, Inc. (BHG)
Molina Healthcare, Inc. (MOH)
Health Revenue Assurance Holdings, Inc. (HRAA)
Medibank Private Limited (MDBPF)
Marpai, Inc. (MRAI)
Business
CVS Health Corporation is a diversified American healthcare company operating primarily in the United States and Puerto Rico. It offers a comprehensive portfolio of health solutions including retail pharmacy services through CVS Pharmacy; pharmacy benefits management under CVS Caremark, which encompasses mail order, specialty pharmacy, infusion services, and formulary management; health insurance products and services through Aetna, providing medical, dental, pharmacy, behavioral health plans, and health management services; and retail health care services via MinuteClinic walk-in medical clinics offering diagnostic testing, vaccinations, and treatment for common illnesses. The company also provides long-term care pharmacy services and health information technology solutions. CVS Health operates approximately 9,900 retail locations and 1,100 walk-in clinics, serving millions of customers across different segments. Founded in 1963 and headquartered in Woonsocket, Rhode Island, CVS Health has undergone significant strategic transformations in recent years. Notably, the company completed the acquisition of Oak Street Health in 2023 for approximately $10.6 billion, expanding its presence in primary care services. In 2024, CVS Health appointed David Joyner as CEO and undertook a major strategic realignment focusing on improving Medicare Advantage margins, cost-cutting initiatives targeting $2 billion in savings, and a reorientation toward enhancing digital health capabilities, including launching a new mobile app designed to streamline prescription management and introducing AI-powered pharmacy chatbots. The company has also been exploring structural options including potentially separating its retail pharmacy and insurance businesses to maximize strategic focus. CVS Health's ongoing expansions into home health care, digital innovation, and integration of health services underline its ambition to be a leading health solutions provider in the evolving healthcare landscape. CVS Health’s main business segments include Health Care Benefits, Pharmacy Services, Retail/Long-Term Care pharmacy, and Corporate Services. Its target markets span individual consumers, employers, health plans, government programs, and long-term care providers. The company holds a significant market share in pharmacy retail, pharmacy benefits management, and health insurance sectors within the US. It leverages multiple brands and subsidiaries to deliver an integrated service model aimed at enhancing patient outcomes, managing costs, and improving access to care. This comprehensive portfolio and strategic focus on innovation, integration of services, and digital transformation position CVS Health as the second-largest healthcare company in the world by revenue, behind UnitedHealth Group. Its ongoing initiatives in 2024 and 2025 reflect efforts to stabilize financial performance, broaden healthcare offerings, and align care delivery with contemporary consumer needs and regulatory environments.